AAPL308.06+13.68 (+4.65%) ▲|ABBV260.28+9.22 (+3.67%) ▲|ABT95.23+3.05 (+3.31%) ▲|ACN137.34+6.21 (+4.74%) ▲|ADBE219.67+8.69 (+4.12%) ▲|AMAT596.44-54.48 (-8.37%) ▼|AMD513.02-27.87 (-5.15%) ▼|AMGN373.03+11.70 (+3.24%) ▲|AMT165.72-0.36 (-0.22%) ▼|AMZN243.42+1.72 (+0.71%) ▲|AVGO360.59-8.76 (-2.37%) ▼|AXP351.20+4.15 (+1.20%) ▲|BA225.98+7.40 (+3.38%) ▲|BAC58.62+0.26 (+0.45%) ▲|BKNG184.56+1.92 (+1.05%) ▲|BLK992.05+11.67 (+1.19%) ▲|BMY57.97+2.16 (+3.87%) ▲|BNY146.19+0.17 (+0.12%) ▲|BRK-B506.38+6.64 (+1.33%) ▲|C139.65-0.48 (-0.34%) ▼|CAT963.39-28.02 (-2.83%) ▼|CL95.20+2.44 (+2.63%) ▲|CMCSA23.75+0.02 (+0.06%) ▲|COF204.38-0.44 (-0.21%) ▼|COP104.26+1.04 (+1.01%) ▲|COST951.40+26.73 (+2.89%) ▲|CRM165.36+2.13 (+1.30%) ▲|CSCO112.72-4.29 (-3.67%) ▼|CVS104.70-0.12 (-0.11%) ▼|CVX168.74+3.05 (+1.84%) ▲|DE620.75-6.88 (-1.10%) ▼|DHR197.24+3.52 (+1.82%) ▲|DIS99.28+3.57 (+3.73%) ▲|DUK129.46+3.69 (+2.93%) ▲|EMR138.93-0.60 (-0.43%) ▼|FDX313.07-0.82 (-0.26%) ▼|GD372.16+10.89 (+3.01%) ▲|GE376.93+1.99 (+0.53%) ▲|GEV1,109.39-24.96 (-2.20%) ▼|GILD131.18+5.21 (+4.14%) ▲|GM75.74+0.22 (+0.29%) ▲|GOOG356.40-1.49 (-0.42%) ▼|GOOGL360.23-0.98 (-0.27%) ▼|GS1,020.83+1.22 (+0.12%) ▲|HD357.29+6.45 (+1.84%) ▲|HON229.59+7.84 (+3.54%) ▲|IBM288.58+2.33 (+0.81%) ▲|INTC119.07-7.95 (-6.26%) ▼|INTU274.74+7.66 (+2.87%) ▲|ISRG425.32+22.94 (+5.70%) ▲|JNJ261.96+7.98 (+3.14%) ▲|JPM333.40-0.68 (-0.20%) ▼|KO83.75+2.46 (+3.02%) ▲|LIN545.51+11.96 (+2.24%) ▲|LLY1,203.65+11.91 (+1.00%) ▲|LMT544.69+22.87 (+4.38%) ▲|LOW226.79+4.87 (+2.19%) ▲|LRCX348.45-42.82 (-10.94%) ▼|MA538.21+15.77 (+3.02%) ▲|MCD280.20+10.77 (+4.00%) ▲|MDLZ60.92+1.57 (+2.65%) ▲|MDT83.16+3.96 (+5.00%) ▲|META584.25-28.66 (-4.68%) ▼|MMM160.71+0.75 (+0.47%) ▲|MO72.64+1.10 (+1.54%) ▲|MRK128.98+3.61 (+2.88%) ▲|MS214.00+2.14 (+1.01%) ▲|MSFT390.56+6.28 (+1.63%) ▲|MU963.56-68.72 (-6.66%) ▼|NEE88.14+1.77 (+2.05%) ▲|NFLX77.79+3.60 (+4.85%) ▲|NKE44.05+0.99 (+2.30%) ▲|NOW105.65-0.15 (-0.14%) ▼|NVDA194.53-3.05 (-1.54%) ▼|ORCL140.17-2.34 (-1.64%) ▼|PEP144.21+3.05 (+2.16%) ▲|PFE24.31+0.43 (+1.78%) ▲|PG150.88+3.45 (+2.34%) ▲|PLTR129.85+4.12 (+3.28%) ▲|PM182.64+4.95 (+2.79%) ▲|QCOM175.15-6.77 (-3.72%) ▼|RTX199.15+7.37 (+3.84%) ▲|SBUX104.31+0.92 (+0.89%) ▲|SCHW96.96+1.18 (+1.23%) ▲|SO97.81+2.69 (+2.83%) ▲|SPG225.49+2.49 (+1.11%) ▲|T20.55+0.07 (+0.34%) ▲|TMO520.99+7.66 (+1.49%) ▲|TMUS177.55+4.49 (+2.59%) ▲|TSLA392.94-32.36 (-7.61%) ▼|TXN291.69-6.72 (-2.25%) ▼|UBER74.40+1.74 (+2.39%) ▲|UNH423.95-2.60 (-0.61%) ▼|UNP281.85+4.12 (+1.48%) ▲|UPS110.39+0.85 (+0.78%) ▲|USB61.56-0.40 (-0.65%) ▼|V360.35+9.27 (+2.64%) ▲|VZ42.56+0.57 (+1.36%) ▲|WFC85.49-0.45 (-0.52%) ▼|WMT112.01+3.19 (+2.93%) ▲|XOM136.75+0.47 (+0.34%) ▲|AAPL308.06+13.68 (+4.65%) ▲|ABBV260.28+9.22 (+3.67%) ▲|ABT95.23+3.05 (+3.31%) ▲|ACN137.34+6.21 (+4.74%) ▲|ADBE219.67+8.69 (+4.12%) ▲|AMAT596.44-54.48 (-8.37%) ▼|AMD513.02-27.87 (-5.15%) ▼|AMGN373.03+11.70 (+3.24%) ▲|AMT165.72-0.36 (-0.22%) ▼|AMZN243.42+1.72 (+0.71%) ▲|AVGO360.59-8.76 (-2.37%) ▼|AXP351.20+4.15 (+1.20%) ▲|BA225.98+7.40 (+3.38%) ▲|BAC58.62+0.26 (+0.45%) ▲|BKNG184.56+1.92 (+1.05%) ▲|BLK992.05+11.67 (+1.19%) ▲|BMY57.97+2.16 (+3.87%) ▲|BNY146.19+0.17 (+0.12%) ▲|BRK-B506.38+6.64 (+1.33%) ▲|C139.65-0.48 (-0.34%) ▼|CAT963.39-28.02 (-2.83%) ▼|CL95.20+2.44 (+2.63%) ▲|CMCSA23.75+0.02 (+0.06%) ▲|COF204.38-0.44 (-0.21%) ▼|COP104.26+1.04 (+1.01%) ▲|COST951.40+26.73 (+2.89%) ▲|CRM165.36+2.13 (+1.30%) ▲|CSCO112.72-4.29 (-3.67%) ▼|CVS104.70-0.12 (-0.11%) ▼|CVX168.74+3.05 (+1.84%) ▲|DE620.75-6.88 (-1.10%) ▼|DHR197.24+3.52 (+1.82%) ▲|DIS99.28+3.57 (+3.73%) ▲|DUK129.46+3.69 (+2.93%) ▲|EMR138.93-0.60 (-0.43%) ▼|FDX313.07-0.82 (-0.26%) ▼|GD372.16+10.89 (+3.01%) ▲|GE376.93+1.99 (+0.53%) ▲|GEV1,109.39-24.96 (-2.20%) ▼|GILD131.18+5.21 (+4.14%) ▲|GM75.74+0.22 (+0.29%) ▲|GOOG356.40-1.49 (-0.42%) ▼|GOOGL360.23-0.98 (-0.27%) ▼|GS1,020.83+1.22 (+0.12%) ▲|HD357.29+6.45 (+1.84%) ▲|HON229.59+7.84 (+3.54%) ▲|IBM288.58+2.33 (+0.81%) ▲|INTC119.07-7.95 (-6.26%) ▼|INTU274.74+7.66 (+2.87%) ▲|ISRG425.32+22.94 (+5.70%) ▲|JNJ261.96+7.98 (+3.14%) ▲|JPM333.40-0.68 (-0.20%) ▼|KO83.75+2.46 (+3.02%) ▲|LIN545.51+11.96 (+2.24%) ▲|LLY1,203.65+11.91 (+1.00%) ▲|LMT544.69+22.87 (+4.38%) ▲|LOW226.79+4.87 (+2.19%) ▲|LRCX348.45-42.82 (-10.94%) ▼|MA538.21+15.77 (+3.02%) ▲|MCD280.20+10.77 (+4.00%) ▲|MDLZ60.92+1.57 (+2.65%) ▲|MDT83.16+3.96 (+5.00%) ▲|META584.25-28.66 (-4.68%) ▼|MMM160.71+0.75 (+0.47%) ▲|MO72.64+1.10 (+1.54%) ▲|MRK128.98+3.61 (+2.88%) ▲|MS214.00+2.14 (+1.01%) ▲|MSFT390.56+6.28 (+1.63%) ▲|MU963.56-68.72 (-6.66%) ▼|NEE88.14+1.77 (+2.05%) ▲|NFLX77.79+3.60 (+4.85%) ▲|NKE44.05+0.99 (+2.30%) ▲|NOW105.65-0.15 (-0.14%) ▼|NVDA194.53-3.05 (-1.54%) ▼|ORCL140.17-2.34 (-1.64%) ▼|PEP144.21+3.05 (+2.16%) ▲|PFE24.31+0.43 (+1.78%) ▲|PG150.88+3.45 (+2.34%) ▲|PLTR129.85+4.12 (+3.28%) ▲|PM182.64+4.95 (+2.79%) ▲|QCOM175.15-6.77 (-3.72%) ▼|RTX199.15+7.37 (+3.84%) ▲|SBUX104.31+0.92 (+0.89%) ▲|SCHW96.96+1.18 (+1.23%) ▲|SO97.81+2.69 (+2.83%) ▲|SPG225.49+2.49 (+1.11%) ▲|T20.55+0.07 (+0.34%) ▲|TMO520.99+7.66 (+1.49%) ▲|TMUS177.55+4.49 (+2.59%) ▲|TSLA392.94-32.36 (-7.61%) ▼|TXN291.69-6.72 (-2.25%) ▼|UBER74.40+1.74 (+2.39%) ▲|UNH423.95-2.60 (-0.61%) ▼|UNP281.85+4.12 (+1.48%) ▲|UPS110.39+0.85 (+0.78%) ▲|USB61.56-0.40 (-0.65%) ▼|V360.35+9.27 (+2.64%) ▲|VZ42.56+0.57 (+1.36%) ▲|WFC85.49-0.45 (-0.52%) ▼|WMT112.01+3.19 (+2.93%) ▲|XOM136.75+0.47 (+0.34%) ▲|
38.5 C
New York
Thursday, July 2, 2026

Tag: programs

Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers – FTRE

NEW YORK, June 22, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Fortrea Holdings, Inc. ("Fortrea" or the...

Pomerantz Law Firm Announces the Filing of a Class Action Against PepGen Inc. and Certain Officers – PEPG

NEW YORK, June 22, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against PepGen Inc. ("PepGen" or the "Company")...

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project as Federal Support for Blockchain Grows

Dr. Anosh Ahmed repurposes West Side warehouse into blockchain innovation center, targeting 250+ jobs and tech-based economic opportunities amid pro-crypto

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project Amid National Pro-Crypto Policy Shift

Dr. Anosh Ahmed converts vacant West Side warehouse into blockchain innovation hub, creating 250+ jobs and advancing tech-driven economic growth aligned with Trump administration’s pro-crypto stance.
Dr. Anosh Ahmed converts vacant West Side warehouse into blockchain innovation hub, creating 250+ jobs and advancing tech-driven economic growth aligned with Trump administration’s pro-crypto stance.

BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions

Treatment with apelin receptor agonist enhanced glycemic control and demonstrated cardioprotective effects, with additive benefits observed in combination with incretin therapy

Nixol Capsules Launch in the UK: A Natural Path to Weight Management and Metabolic Support

Nixol introduces a new natural supplement in the United Kingdom to support metabolism, curb cravings, and promote healthy weight loss management using vegan-friendly ingredients.
Nixol introduces a new natural supplement in the United Kingdom to support metabolism, curb cravings, and promote healthy weight loss management using vegan-friendly ingredients.

No Deposit Casino 2025: Uptown Aces Launches No Deposit Bonus

Uptown Aces has unveiled a new no deposit bonus to incentivize new casino players looking to explore the online gaming world.
Uptown Aces has unveiled a new no deposit bonus to incentivize new casino players looking to explore the online gaming world.

Gan & Lee Pharmaceuticals Presented Multiple Results in Novel Diabetes Therapies at the American Diabetes Association’s 85th Scientific Sessions

In a Phase 2a clinical trial, the GLP-1 RA bofanglutide injection demonstrated a favorable safety and tolerability profile after 23 weeks of once weekly...

Gan & Lee Pharmaceuticals Presented Multiple Results in Novel Diabetes Therapies at the American Diabetes Association’s 85th Scientific Sessions

In a Phase 2a clinical trial, the GLP-1 RA bofanglutide injection demonstrated a favorable safety and tolerability profile after 23 weeks of once weekly...

New data demonstrates robust efficacy of Vyepti® (eptinezumab) in otherwise difficult-to-treat patients with severe migraine

The full results of the phase IV RESOLUTION trial were presented at the European Academy of Neurology 2025 Annual Congress, where Vyepti® (eptinezumab) demonstrated...

New data demonstrates robust efficacy of Vyepti® (eptinezumab) in otherwise difficult-to-treat patients with severe migraine

The full results of the phase IV RESOLUTION trial were presented at the European Academy of Neurology 2025 Annual Congress, where Vyepti® (eptinezumab) demonstrated...

New data from phase III trial confirms efficacy of Vyepti® (eptinezumab) in Asian population with chronic migraine

The full results of the phase III registrational SUNRISE trial were presented at the European Academy of Neurology 2025 Annual Congress, where eptinezumab demonstrated statistically...

New data from phase III trial confirms efficacy of Vyepti® (eptinezumab) in Asian population with chronic migraine

The full results of the phase III registrational SUNRISE trial were presented at the European Academy of Neurology 2025 Annual Congress, where eptinezumab demonstrated statistically...

Gan & Lee Pharmaceuticals Presented Multiple Results in Novel Diabetes Therapies at the American Diabetes Association’s 85th Scientific Sessions

In a Phase 2a clinical trial, the GLP-1 RA bofanglutide injection demonstrated a favorable safety and tolerability profile after 23 weeks of once weekly...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPrograms